Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024

Tomas Kauer - Moderator

Sep 9, 2024 - 14:00

Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024

Tags:

Previous Article

BW LPG Limited “ Ex dividend USD 0.58 on the Oslo Stock Exchange today

Dollar steadies, yen slips as traders grapple with Fed rate-cut outlook

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator

Related Posts

Embattled Astra scores DOD contract to develop point-to-point cargo delivery from space

Embattled Astra scores DOD contract to develop point-to...

Tomas Kauer - Mode... Oct 25, 2024

This device charger has Apple’s Find My tech built in

Tomas Kauer - Mode... Oct 2, 2024

Ashton Kutcher’s Sound Ventures backs Fei-Fei Li’s World Labs in continued AI push

Ashton Kutcher’s Sound Ventures backs Fei-Fei Li’s Worl...

Tomas Kauer - Mode... Oct 30, 2024